{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-171517","form_type":"8-K","ticker":"IMA","cik":"0001835579","company_name":"ImageneBio, Inc.","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.714171+00:00","generated_at":"2026-06-25T02:54:26.465310+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Ikena Oncology shareholders elect three Class I directors and ratify EY as auditor","bullets":["Elected Iain D. Dukes (23.9M for), Maria Koehler (24.6M for), Otello Stampacchia (23.3M for) to 3-year terms.","Ratified Ernst & Young as independent auditor for FY 2022 with 28.5M votes for, 1,095 against.","Meeting held June 9, 2022; all stockholder proposals passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-171517","json":"https://secwatch.observer/filing/0001193125-22-171517.json","markdown":"https://secwatch.observer/filing/0001193125-22-171517.md","text":"https://secwatch.observer/filing/0001193125-22-171517.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835579/000119312522171517/0001193125-22-171517-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835579/000119312522171517/d322633d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:54:26.465310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}